News & Updates

Show Multimedia Only

Weight-loss outcomes in Asians with high BMI better with cagrilintide–semaglutide vs semaglutide

05 May 2026 by

Individuals with overweight or obesity in East Asia shed more weight following treatment with the fixed-dose combination of cagrilintide plus semaglutide than with semaglutide alone, as shown in the phase 3a REDEFINE 5 trial.

Weight-loss outcomes in Asians with high BMI better with cagrilintide–semaglutide vs semaglutide

05 May 2026

Brolucizumab a viable alternative in proliferative diabetic retinopathy

02 May 2026 by

In the treatment of patients with proliferative diabetic retinopathy, brolucizumab outperforms panretinal laser photocoagulation in terms of preserving visual acuity, according to the international phase III CONDOR trial.

Brolucizumab a viable alternative in proliferative diabetic retinopathy

02 May 2026

Women with diabetes prone to sexual dysfunction

02 May 2026

Sexual dysfunction (SD) is common among women with diabetes and appears to be driven by age, disease duration, and depression, among others, a study has found.

Women with diabetes prone to sexual dysfunction

02 May 2026

Semaglutide may avert adult-onset epilepsy in patients with diabetes

01 May 2026 by

Treatment with semaglutide appears effective in reducing the risk of adult-onset epilepsy or seizures relative to sodium–glucose cotransporter-2 inhibitors (SGLT2i) and other glucose-lowering drugs (GLDs) in patients with type 2 diabetes mellitus (T2DM), according to a study presented at AAN 2026.

Semaglutide may avert adult-onset epilepsy in patients with diabetes

01 May 2026

Losing weight may protect men from having erectile dysfunction

30 Apr 2026

Men in their 40s who become or remain obese are at significantly higher risk of developing erectile dysfunction (ED), regardless of age, comorbidities, and lifestyle factors, suggests a study.

Losing weight may protect men from having erectile dysfunction

30 Apr 2026

Weight cycling in adulthood linked to increased risk of gestational weight gain

29 Apr 2026

Pregnant women with a history of weight cycling as adults are likely to experience gestational weight gain, according to a study.

Weight cycling in adulthood linked to increased risk of gestational weight gain

29 Apr 2026

Original New Drug Application Approvals by US FDA (16-31 March 2026)

29 Apr 2026

New drug applications approved by US FDA as of 16-31 March 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 March 2026)

29 Apr 2026

Original New Drug Application Approvals by US FDA (1-15 April 2026)

29 Apr 2026

New drug applications approved by US FDA as of 1-15 April 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 April 2026)

29 Apr 2026

Suboptimal use of diabetes management technology in children and adolescents with T1D

29 Apr 2026 by

A Hong Kong territory-wide study has found that despite improved glycaemic outcomes and device reimbursement, use of continuous glucose monitoring systems (CGMS) and/or automated insulin delivery (AID) systems remains suboptimal in patients ≤18 years old with type 1 diabetes (T1D), particularly among adolescents, alluding to barriers beyond cost.

Suboptimal use of diabetes management technology in children and adolescents with T1D

29 Apr 2026

Maternal obesity may elevate bile acids in breast milk

24 Apr 2026

Maternal obesity appears to increase bile acid (BA) levels in breast milk, which may have implications for neonatal digestion, maturation, and health.

Maternal obesity may elevate bile acids in breast milk

24 Apr 2026

News & Updates

Showing Endocrinology articles

Showing

Specialty:

Weight-loss outcomes in Asians with high BMI better with cagrilintide–semaglutide vs semaglutide

Weight-loss outcomes in Asians with high BMI better with cagrilintide–semaglutide vs semaglutide

Brolucizumab a viable alternative in proliferative diabetic retinopathy

Brolucizumab a viable alternative in proliferative diabetic retinopathy

Women with diabetes prone to sexual dysfunction

Women with diabetes prone to sexual dysfunction

Semaglutide may avert adult-onset epilepsy in patients with diabetes

Semaglutide may avert adult-onset epilepsy in patients with diabetes

Losing weight may protect men from having erectile dysfunction

Losing weight may protect men from having erectile dysfunction

Weight cycling in adulthood linked to increased risk of gestational weight gain

Weight cycling in adulthood linked to increased risk of gestational weight gain

Original New Drug Application Approvals by US FDA (16-31 March 2026)

Original New Drug Application Approvals by US FDA (16-31 March 2026)

Original New Drug Application Approvals by US FDA (1-15 April 2026)

Original New Drug Application Approvals by US FDA (1-15 April 2026)

Suboptimal use of diabetes management technology in children and adolescents with T1D

Suboptimal use of diabetes management technology in children and adolescents with T1D

Maternal obesity may elevate bile acids in breast milk

Maternal obesity may elevate bile acids in breast milk